Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 233

Showing 1-25 of 233 citing articles:

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 390
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 240
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
Yunhao Chen, Yanchun Zhao, Junru Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 215
Role of m6A RNA methylation in cardiovascular disease (Review)
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 215
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 172
m6A transferase METTL3‐induced lncRNA ABHD11‐AS1 promotes the Warburg effect of non‐small‐cell lung cancer
Lei Xue, Jun Li, Yi-Hui Lin, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2649-2658
Closed Access | Times Cited: 140
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 139
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 118
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 110
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
Yiming Xu, Dandan Lv, Chao Yan, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 108
N6-methyladenosine and Neurological Diseases
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 90
RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner
Dan Yu, Min Pan, Yanshi Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 78
The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma
Lifang Ma, Xiangfei Xue, Xiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 68
A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR
Hongmei Liu, Yuxin Xu, Bing Yao, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 111
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1
Huimin Guo, Bei Wang, Kaiyue Xu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 88
Activation of YAP1 by N6-Methyladenosine–Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma
Yunhao Chen, Zhenan Ling, Xianlei Cai, et al.
Cancer Research (2021) Vol. 82, Iss. 4, pp. 599-614
Open Access | Times Cited: 80
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
Xiangyuan Luo, Mengdie Cao, Fan Gao, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 71
The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension
Yuhan Qin, Yong Qiao, Linqing Li, et al.
Life Sciences (2021) Vol. 274, pp. 119366-119366
Closed Access | Times Cited: 63
METTL3/N6‐methyladenosine/ miR‐21‐5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF‐κB pathway activation
Erpeng Liu, Lei Lv, Yonghao Zhan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 16, pp. 7660-7674
Open Access | Times Cited: 62
Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice
Praveen Kumar Dubey, Mallikarjun Patil, Sarojini Singh, et al.
Molecular and Cellular Biochemistry (2021) Vol. 477, Iss. 1, pp. 129-141
Open Access | Times Cited: 58
N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin, Feng Wang, Jian Chen, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 58
The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Chao‐Yue Sun, Cao Di, Bin-Bin Du, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2744-2758
Open Access | Times Cited: 48
m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer
Xiaoran Duan, Li Yang, Liuya Wang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 27
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top